Hudson Bay Capital Management LP Regeneron Pharmaceuticals, Inc. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

A detailed history of Hudson Bay Capital Management LP transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 29,352 shares of REGN stock, worth $21 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

29,352

Previous 35,000 16.14%

Holding current value

$21 Million

Previous $36.8 Million 16.12%

% of portfolio

0.14%

Previous 0.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $13.6 Million - $16 Million	13,294 Added 82.79%	29,352 $30.9 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $14.2 Million - $17.2 Million	16,058 New	16,058 $16.9 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $32.2 Million - $36.6 Million	41,500 New	41,500 $36.4 Million
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $420,018 - $498,210	600 New	600 $431,000
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $9.46 Million - $10.3 Million	13,400 New	13,400 $9.67 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $18 Million - $21.2 Million	-38,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $223,365 - $274,100	-500 Reduced 1.3%	38,000 $18 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $18.4 Million - $23.4 Million	38,500 New	38,500 $18.6 Million
Q1 2020 May 14, 2020	SELL	$336.18 - $494.43 $10.1 Million - $14.8 Million	-30,000 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$274.13 - $376.51 $4.8 Million - $6.59 Million	-17,500 Reduced 36.84%	30,000 $11.3 Million
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $6.84 Million - $7.96 Million	25,000 Added 111.11%	47,500 $13.2 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $6.74 Million - $9.33 Million	22,500 New	22,500 $7.04 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $5.04 Million - $6.05 Million	-15,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $3.51 Million - $4.09 Million	-10,000 Reduced 40.0%	15,000 $6.06 Million
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $4.27 Million - $5.17 Million	15,000 Added 150.0%	25,000 $8.63 Million
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $3.16 Million - $3.94 Million	10,000 New	10,000 $3.44 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Regeneron Pharmaceuticals, Inc. Transaction History